The BMP2K Knockout A-549 Polyclonal Cells are a CRISPR/Cas9-mediated knockout cell population that targets the BMP2K gene in the A?549 human lung epithelial cell line. As a polyclonal pool, this product contains a diverse set of gene-disrupted cells, collectively providing a loss-of-function model without clonal selection. This format is well-suited for functional genomics and pathway analysis experiments where heterogeneous knockout is acceptable, allowing researchers to bypass the time-intensive process of isolating single-cell clones.
The A-549 cell line is a widely used in vitro model derived from the lung adenocarcinoma of a 58-year-old Caucasian male. It exhibits adherent epithelial growth and retains properties of alveolar type II cells, making it relevant for studies in non-small-cell lung cancer, drug metabolism, and respiratory biology. A-549 cells are frequently employed in assays examining proliferation, migration, invasion, and response to anticancer agents, providing a robust platform for gene function studies in a cancer-relevant background.
BMP2K (BMP?2?inducible kinase) is a serine/threonine kinase that serves as a negative feedback regulator in bone morphogenetic protein (BMP) signaling. Following induction by BMP2 or BMP4, BMP2K phosphorylates receptor-activated SMAD transcription factors (SMAD1, SMAD5, SMAD8), leading to their inactivation. This action attenuates BMP?driven transcription, including the expression of osteogenic genes such as RUNX2 and ALPL. BMP2K functions downstream of BMP receptors (BMPR1A, BMPR2) and interacts with inhibitory SMADs (SMAD6, SMAD7), thereby fine-tuning cellular responses to BMP ligands.
In the A?549 lung adenocarcinoma context, disruption of BMP2K can help dissect the kinase??s role in modulating BMP pathway activity and its consequences for cancer cell behavior. BMP signaling exerts context-dependent effects, and loss of this negative regulator may shift the balance between pro? and anti?tumorigenic outcomes. The BMP2K knockout thus enables researchers to investigate whether the kinase acts as a suppressor or facilitator of proliferation, epithelial?mesenchymal transition, or chemoresistance in a lung cancer model system.
These polyclonal knockout cells are suitable for a variety of experimental techniques, including western blotting to assess SMAD phosphorylation status, RT?qPCR to quantify downstream target gene expression, alkaline phosphatase activity assays as a readout of BMP pathway output, and cell?based proliferation, migration, and invasion assays. They support applications ranging from detailed signaling studies and functional genomics screens to drug candidate evaluation in a BMP?perturbed setting. For further details or to inquire about custom products, please contact Ascent Research.
